EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens

Andreas M Kany, Franziska Fries, Carsten E Seyfert, Christoph Porten, Selina Deckarm, María Chacón Ortiz, Nelly Dubarry, Swapna Vaddi, Miriam Große, Steffen Bernecker, Birthe Sandargo, Alison V Müller und 4 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Andreas M Kany und 15 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Saarbrücken 66123, Germany. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Zebrafish, Microbial Sensitivity Tests. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz-Gemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsZebrafishMicrobial Sensitivity TestsAnimalsMicePseudomonas aeruginosaAcinetobacter baumanniiDisease Models, AnimalFemaleHumansPseudomonas InfectionsEscherichia coliUrinary Tract InfectionsPeritonitisGram-Negative BacteriaGram-Negative Bacterial Infections

Stichwörter der Autor:innen

UTIdarobactinsin vivo infection modelsnatural product antibioticperitonitispharmacokinetics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Saarbrücken 66123, Germany.
  • Department of Pharmacy, Saarland University, Saarbrücken 66123, Germany.
  • Deutsches Zentrum für Infektionsforschung (DZIF) e.V., Braunschweig 38124, Germany.
  • Evotec, Lyon 69007, France.
  • Evotec, Alderly Park SK10 4TG, United Kingdom.
  • Helmholtz Centre for Infection Research (HZI), Department Microbial Drugs, Braunschweig 38124, Germany.

ORCID-Profile: Marc Stadler, Jennifer Herrmann, Rolf Müller

Förderung

  • Helmholtz-Gemeinschaft

Zitieren

APA

Kany, A. M., Fries, F., Seyfert, C. E., Porten, C., Deckarm, S., Chacón Ortiz, M., Dubarry, N., Vaddi, S., Große, M., Bernecker, S., Sandargo, B., Müller, A. V., Bacqué, E., Stadler, M., Herrmann, J., & Müller, R. (2024). In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00687

Vancouver

Kany AM, Fries F, Seyfert CE, Porten C, Deckarm S, Chacón Ortiz M, et al. In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00687

BibTeX
@article{Kany2024,
  author = {Kany, Andreas M and Fries, Franziska and Seyfert, Carsten E and Porten, Christoph and Deckarm, Selina and Chacón Ortiz, María and Dubarry, Nelly and Vaddi, Swapna and Große, Miriam and Bernecker, Steffen and Sandargo, Birthe and Müller, Alison V and Bacqué, Eric and Stadler, Marc and Herrmann, Jennifer and Müller, Rolf},
  title = {In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00687}
}
Kostenlos starten →